Medicine and Dentistry

1. Patient 100%
2. In Vitro 91%
3. Emergency 83%
4. Heart Output 83%
5. Laparotomy 83%
6. DNA 83%
7. Fluid Therapy 83%
8. Antibody-Drug Conjugate 83%
9. Triple Negative Breast Cancer 83%
10. Epidermal Growth Factor Receptor 83%
11. Cancer Growth 83%
12. Cyclin-Dependent Kinase 83%
13. Therapeutic Procedure 52%
14. Tumor Xenograft 36%
15. Therapeutics 36%
16. Toxicity 36%
17. Cancer Cell Line 27%
18. B-Cell Chronic Lymphocytic Leukemia 27%
19. Leukemia Cell 27%
20. DNA Base 27%
21. Breast 27%
22. Cells 25%
23. Cyclin Dependent Kinase Inhibitor 25%
24. Surgical Emergency 23%
25. Infusion Fluid 23%
26. Mortality 23%
27. Hemodynamic 23%
28. Intervention Trial 23%
29. Cell Cycle 16%
30. Transcriptomics 16%
31. Tumor Cell 16%
32. Breast Cancer 16%
33. Chemotherapy 16%
34. Elective Surgery 11%
35. Technology Assessment 11%
36. Hospital 11%
37. Morbidity 11%
38. Randomized Controlled Trial 11%
39. Health Technology 11%
40. Mortality Rate 11%
41. Complication 11%
42. Health 11%
43. Proliferating Cell Nuclear Antigen 8%
44. Tumor Spheroid 8%
45. Xenograft 8%
46. Analysis 8%
47. Cyclin E 8%
48. Immunocompetent Cell 8%
49. Tumor Progression 8%
50. Oncogene 8%